瑞财经 吴文婷 "辣条第一股"再现人事变动，继CEO离任后，CFO也即将离开。 近日，卫龙美味发布公告称，于2025年7月9日，彭宏志因个人职业发展安排，已辞任公司执行董事、首 席财务官等职务。彭宏志的上述辞任将自2025年8月31日结束后生效。 同时，董事会宣布，公司执行董事余风将自彭宏志正式辞任后担任首席财务官及授权代表，自2025年9 月1日起生效。 卫龙美味称，上述事项不会影响公司相关工作的正常运作。 公开资料显示，彭宏志，43岁，在运营管理方面有超过11年经验。自2019年6月至2023年2月，其主要负 责集团财务中心以及其他管理工作；自2023年3月起主要负责集团财务中心及海外事业发展中心的管理 工作。年报显示，彭宏志2024年年薪为1821.5万元。 執行董事辭任 及 首席執行官之變動 | | | | | | | | Welfare, | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | For the year ended | | | | Discretionary | Share-based Contribution pa ...

Core Viewpoint - The Huangshi Market Supervision Administration has conducted a food safety inspection, revealing that out of 624 food samples tested, 613 passed while 11 were found to be non-compliant, highlighting ongoing food safety concerns in the region [3][4]. Summary by Categories Inspection Results - A total of 624 food samples were tested, covering 21 categories including grain products, edible oils, pastries, alcoholic beverages, meat products, beverages, condiments, tea, eggs, dairy, vegetable products, frozen foods, canned goods, aquatic products, starch, honey, fruit products, convenience foods, catering foods, and agricultural products [3]. - Of the 624 samples, 613 were compliant, resulting in a compliance rate of approximately 98.24% [4]. Non-compliance Details - The 11 non-compliant samples included: - 1 batch of condiments with excessive sulfur dioxide residue - 3 batches of vegetable products with violations related to lemon yellow, benzoic acid, and sorbic acid - 2 batches of agricultural products with pesticide residues (thiamethoxam and enrofloxacin) - 5 batches of catering foods with issues related to anionic synthetic detergents, sodium saccharin, sweeteners, and coliform bacteria [4][5]. Follow-up Actions - The Huangshi Market Supervision Administration has mandated immediate investigation and handling of the non-compliant products, including actions such as removal from shelves, recalls, and sales suspensions, along with further legal investigations [5].

Core Viewpoint - Zhejiang Dongri, once a high-flying stock due to the "brain-computer interface" concept, saw its stock price plummet after clarifying that its main business is unrelated to this concept, leading to a significant market correction [1][2][4] Group 1: Stock Performance - From June 16 to June 27, Zhejiang Dongri's stock price surged for 10 consecutive trading days, with 6 days hitting the daily limit, resulting in a cumulative increase of 105.16% [2][3] - On June 30, the stock opened at 26.82 yuan, down 6.35%, and closed at the daily limit of 25.78 yuan, marking a decline of 9.99% [1] Group 2: Company Announcements - On June 27, Zhejiang Dongri issued a "Severe Abnormal Fluctuation Announcement," clarifying that its main business involves managing vegetable markets and selling tofu, with no connection to the "brain-computer interface" [1][2] - The company had previously issued multiple announcements, including a "Risk Warning Announcement," emphasizing that its daily operations do not involve the "brain-computer interface" business [3][4] Group 3: Market Manipulation Concerns - The stock's prior surge was characterized as speculative trading, with indications of potential market manipulation, especially given the company's clarifications about its business focus [2][3] - The misleading nature of the stock's rise based on the "brain-computer interface" concept has raised concerns about investor protection and the need for regulatory scrutiny [4]

骨头汤 骨头汤是传统饮食中的一道名食，因其治愈和营养特性而备受尊崇。骨头汤是用动物的骨头和结缔组织 熬煮而成的，富含胶原蛋白、明胶和必需氨基酸。这些营养物质很容易被人体吸收，从而促进胶原蛋白 的生成并支持皮肤健康。除了胶原蛋白，骨头汤还含有钙、镁和磷等矿物质，它们能进一步增强皮肤的 活力。 多脂鱼 像鲑鱼、马鲛鱼和金枪鱼这样的多脂鱼富含欧米伽-3脂肪酸，它能通过减少炎症、保持皮肤水分来支持 皮肤健康。此外，多脂鱼也是海洋胶原蛋白的极佳来源，这种胶原蛋白的生物利用度高，能有效增加皮 肤的弹性和水分。海洋胶原蛋白中的肽来自于鱼皮和鱼鳞，它们很容易被人体吸收，使其成为那些希望 增加胶原蛋白摄入量的人的理想选择。 鸡蛋 鸡蛋是一种用途多样和营养丰富的食物，它可以显著地增加胶原蛋白的生成量。虽然鸡蛋不直接含有胶 原蛋白，但它富含脯氨酸，这是一种对胶原蛋白合成起到至关重要作用的氨基酸。此外，蛋清含有的赖 氨酸是另一种支持胶原蛋白形成的氨基酸。蛋黄提供的重要营养物质（如维生素D和健康的脂肪）也有 助于保持皮肤健康。 柑橘类水果 要想让皮肤看起来滋润有光泽，你所吃的食物与涂抹的护肤品同等重要。虽然注射血清和涂抹防衰老的 面霜 ...

Group 1 - The core viewpoint of the news highlights the significant stock price fluctuations of Zhejiang Dongri, which experienced a cumulative increase of 100% over ten consecutive trading days, driven by the hype surrounding brain-computer interface stocks due to recent clinical advancements by Neuralink [1] - Zhejiang Dongri's main business involves the operation and management of agricultural product wholesale markets, fresh food distribution, and tofu production, with no direct involvement in brain-computer interface technology [1] - As of the end of May 2025, Zhejiang Dongri's associated company, Peianmei (Zhejiang) Technology Co., Ltd., reported a total revenue of 28,700 yuan and a net loss of 661,400 yuan, indicating minimal impact on the company's overall performance [1] Group 2 - The speculative trading behavior surrounding certain stocks is driven by investors' desire for quick profits, leading to a false sense of trading activity and price increases, despite the lack of fundamental value [3] - The current trading environment is characterized by extreme volatility, where stocks can experience rapid price increases followed by sharp declines, often resulting in significant losses for ordinary investors [3] - As of the latest report, Zhejiang Dongri's stock is trading at 25.78 yuan per share, reflecting a decline of 9.99% [4]

Core Viewpoint - Zhejiang Dongri has experienced a significant stock price surge due to market speculation linking it to brain-computer interface technology, despite its primary business being in agricultural products and related services [1][2][8]. Company Overview - Zhejiang Dongri operates in the agricultural sector, focusing on wholesale market operations, food distribution, and tofu production [8]. - The company has adopted a "1+2+N" business model, where "1" refers to market operations, "2" includes food distribution and tofu production, and "N" encompasses various technology-driven initiatives [3]. Recent Developments - In 2024, Zhejiang Dongri established Peianmei Technology Co., Ltd. to collaborate with medical universities on special medical foods and nutrition therapy [6]. - A strategic cooperation intention was announced with Capital Medical University to advance brain-computer interface technology, which has led to speculation and a surge in stock price [6][7]. Stock Performance - From June 17 to June 27, Zhejiang Dongri's stock price increased by 99%, achieving six trading limit-ups in nine days [2][8]. - The company reported a cumulative price increase of 100% over ten trading days, prompting a notice of abnormal trading activity [8]. Financial Impact - Peianmei reported minimal financial impact on Zhejiang Dongri, with a revenue of 2.87 thousand yuan and a net loss of 66.14 thousand yuan for the current year [8]. - The company aims to achieve over 900 million yuan in main business revenue in 2025, with approximately 1.7 million yuan in revenue reported for the first quarter of 2024 [9].

企查查APP显示，近日，北京祖名豆制品有限公司成立，法定代表人为李国平，经营范围包含：食品生 产；食品销售；食用农产品批发。企查查股权穿透显示，该公司由祖名股份（003030）全资持股。(人 民财讯) ...

Core Viewpoint - The recent announcement by Zunming Co., Ltd. regarding the transfer of 50.83% equity in Zunming Xiangxiang indicates a strategic retreat due to financial struggles and declining profitability [1][3][7] Group 1: Financial Performance - Zunming Xiangxiang has accumulated losses of 29.16 million yuan since its establishment, with the company facing high debt levels and cash significantly lower than short-term liabilities [1][2] - In 2024, Zunming Xiangxiang reported revenue of 72.03 million yuan but incurred a loss of 23.52 million yuan, while the first quarter of 2025 showed revenue of 21.69 million yuan with a loss of 0.38 million yuan [2] - Zunming Co. itself reported a loss of 25.14 million yuan in 2024 and a further loss of 5.91 million yuan in the first quarter of 2025 [2] Group 2: Expansion Strategy - Since its IPO in January 2021, Zunming Co. has pursued aggressive expansion, establishing production bases in various regions, including Jiangsu, Hubei, Shanxi, Guizhou, and Beijing [3] - The establishment of Zunming Xiangxiang was part of a strategy to penetrate the Beijing-Tianjin-Hebei market, which has now been reversed with the equity transfer [3][4] Group 3: Operational Challenges - Despite an increase in production capacity, Zunming Co. has seen a decline in the utilization rates of its facilities, with actual utilization rates for fresh bean products at only 40% and for plant protein beverages at 35% [5][6] - The company has faced a significant drop in profit margins, with gross margin decreasing from 33% in 2020 to 22.74% in 2024, and net margin falling from 8% to 2.34% over the same period [6] Group 4: Debt and Financial Health - Zunming Co.'s debt-to-asset ratio has risen from approximately 40% at the time of its IPO to 55.61% in 2024, indicating increasing financial pressure [6] - The company has 1.42 billion yuan in cash against short-term interest-bearing liabilities of 6.56 billion yuan, resulting in a cash-to-short-term debt ratio of only 0.22 [6]

证券之星吴凡 豆制品生产商祖名股份（003030）(003030.SZ)近期发布的2024年年报显示，公司实现营收16.64亿元， 同比增长12.58%，归母净利润亏损2513.61万元，同比大幅下降162.12%，这是公司自2021年上市后首次 盈利告负。这也意味着，祖名股份于2024年4月推出的员工持股计划中，第一个解锁期公司层面的业绩 指标未达成。 证券之星了解到，公司产能爬坡释放过程中折旧、能耗、人员工资等成本增加，以及部分生产基地改造 影响等综合因素是侵蚀公司利润的主因之一。另外，由于2024年豆制品行业竞争激烈，祖名股份投入的 销售费用创下历史新高的2.64亿元，也是导致公司归母净利润出现亏损的关键因素。而在今年一季度， 公司继续呈现"增收不增利"之态，营收同比增长16.71%至4.45亿元，归母净利润亏损591.39万元，同比 大幅下降160.93%，这也是公司连续四个单季度净利润呈现亏损。 生产基地尚未达到满产状态 2024年，祖名股份营业总成本达到16.96亿元，较上年同期增长约19.52%，总成本增速高于同期12.58% 的营收增速，其中生鲜豆制品的营业成本较上年大幅增长23.15%，高于 ...

昆明市市场监督管理局 昆明市市场监督管理局2025年第9期食品安全监督抽检信息公告 根据《中华人民共和国食品安全法》及其《食品安全监督抽检和风险监测工作规范》等规定，现将昆明市市场监督管理局2025年第9期食品安全监督 抽检信息公告如下： 本期公布的食品安全监督抽检产品为糕点、调味品、蛋制品、淀粉及淀粉制品、饼干、豆制品等，抽检依据：GB 2760-2024《食品安全国家标准 食品 添加剂使用标准》、GB 2762-2022《食品安全国家标准 食品中污染物限量》、GB 2763-2021《食品安全国家标准 食品中农药最大残留限量》等标准 及产品明示标准的要求。抽检项目包括：铅（以Pb计）、苯甲酸及其钠盐（以苯甲酸计）、山梨酸及其钾盐（以山梨酸计）、脱氢乙酸及其钠盐（以 脱氢乙酸计）、糖精钠（以糖精计）、甜蜜素（以环己基氨基磺酸计）、安赛蜜、菌落总数、大肠菌群等指标。 特此公告。 2025年6月2日 | | 抽检不合格样品相关信息统计表（2025-9） | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | -- ...